In April 2018, Pear Therapeutics and Sandoz formed a commercialisation partnership for Pear’s...
- Syphilis testing: surging infection rate may have limited market impact
- “At least I have my health”: the reputational impact of AI in healthcare
- US FDA to modernise medical device approval process
- NHS to offer better access to glucose monitors for diabetes patients
- Apple Watch heart trial recruits 400,000 participants
New app for opioid use disorder shows the potential of digital therapies
In April 2018, Pear Therapeutics and Sandoz formed a commercialisation partnership for Pear’s leading pipeline assets, reSET and re-SET-O. The deal would combine Pear’s expertise in software-based therapeutics with Sandoz’s global reach and strong marketing force.
Syphilis testing: surging infection rate may have limited market impact
While the rising rate of syphilis infections represents a very important and serious public health concern, GlobalData does not expect that this sexual health crisis will have as strong an impact on the syphilis diagnostics market as one might expect.
Antibiotic-resistance threat grows as more patients go under the knife
Minimally invasive surgeries have spurred a growth in procedures, especially for patients with conditions that are difficult to treat, such as osteoarthritis.
AI could revolutionise dermatology, but key hurdles remain
The use of artificial intelligence (AI) in the field of dermatology could provide significant benefit to both patients and dermatologists alike. Not only does AI in dermatology have potential in alerting people when they may need to see a doctor (usually through the use of a smart device), it can also be used to create an educational resource for medical students, as well as a confidence boost to physicians making a differential diagnosis.
Are you a manufacturer, importer, distributor or wholesaler of healthcare products? RAQAC has the specialised knowledge to help you navigate the Canadian regulatory requirements for registering and marketing products.
Apple Heart trial could expand electrophysiology market
Wearable technology is quickly advancing into healthcare and diagnostics, where Apple recently announced that 400,000 participants were enrolled in the Apple Heart trial, a study aimed at screening atrial fibrillation.
“At least I have my health”: the reputational impact of AI in healthcare
As AI becomes increasingly commonplace in the medical device sector, the process of how safety and efficacy are demonstrated will be a significant consideration for clinicians seeking to implement the devices, regulatory agencies and device manufacturers. Marcus Smith, managing director EMEA at Polecat, explains.
Big data predictive analytics: the future of medical devices
Medical devices generate huge amounts of essential, timely data that can have significant clinical impact. New technologies make it possible to effectively capture this data; however, discovering new actionable insights has not been common, with data captured from medical devices remaining vastly underutilised and wasted.
US FDA to modernise medical device approval process
The US Food and Drug Administration (FDA) is planning to modernise the medical device clearance process in a bid to address the complexity of new technologies.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.